Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016-Reference-Cited by-同舟云学术

Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016

Published:2020-03 Issue:3 Volume:55 Page:105883
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Kuo Shu-Chen^ORCID,Liu Chun-Eng,Lu Po-Liang,Chen Yao-Shen,Lu Min-Chi,Ko Wen-Chien,Hsueh Po-Ren,Chuang Yin-Ching,Wang Fu-Der

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference31 articles.

1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015;Collaborators;Lancet Infect Dis,2017

2. Inadequate antimicrobial treatment of infections - A risk factor for hospital mortality among critically ill patients;Kollef;Chest,1999

3. Early mortality in patients with community-acquired pneumonia: causes and risk factors;Garcia-Vidal;Eur Respir J,2008

4. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society;Kalil;Clin Infect Dis,2016

5. Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters;Cheng;J Microbiol Immunol Infect,2016

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of ceftolozane/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017–2021, China;Journal of Global Antimicrobial Resistance;2024-09

2. Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012–2021);Heliyon;2024-07

3. Genomic analysis and antimicrobial activity of β-lactam/β-lactamase inhibitors and other agents against KPC-producing Klebsiella pneumoniae clinical isolates from Brazilian hospitals;Scientific Reports;2023-09-05

4. Promising treatments for refractory pneumonia caused by multidrug-resistant Klebsiella pneumoniae;Journal of Drug Delivery Science and Technology;2023-09

5. The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis;BMC Microbiology;2023-07-28